High Doses of Colchicine Act As "Silver Bullets" Against Severe COVID-19

被引:7
|
作者
Lilov, Alexander [1 ]
Palaveev, Kiril [1 ]
Mitev, Vanyo [2 ]
机构
[1] Sofia Dist Hosp, Specialized Hosp Act Treatment Pneumopneumonia Pht, Pulmonol, Sofia, Bulgaria
[2] Med Univ Sofia, Chem & Biochem, Sofia, Bulgaria
关键词
obesity; survival; colchicine; nlrp3; inflammasome; covid-19;
D O I
10.7759/cureus.54441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 48-year-old patient with a weight of 120 kg with type 2 diabetes mellitus, hypertension, and gout was hospitalized on the third day of the COVID-19 diagnosis. His general condition is relatively good, oxygen saturation is 89%. Despite starting standard treatment, on the seventh day from the onset of symptoms, the patient deteriorated sharply (oxygen saturation dropped to 74%). The negative development of the disease is interrupted with a loading dose of colchicine of 6 mg. This is a typical case of the life-saving effect of high but safe doses of colchicine in high-risk COVID-19 patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)
    Absalon-Aguilar, Abdiel
    Rull-Gabayet, Marina
    Perez-Fragoso, Alfredo
    Mejia-Dominguez, Nancy R.
    Nunez-Alvarez, Carlos
    Kershenobich-Stalnikowitz, David
    Sifuentes-Osornio, Jose
    Ponce-de-Leon, Alfredo
    Gonzalez-Lara, Fernanda
    Martin-Nares, Eduardo
    Montesinos-Ramirez, Sharon
    Ramirez-Alemon, Martha
    Ramirez-Rangel, Pamela
    Marquez, Manlio F.
    Carlos Plata-Corona, Juan
    Juarez-Vega, Guillermo
    Gomez-Martin, Diana
    Torres-Ruiz, Jiram
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (01) : 4 - 14
  • [42] Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)
    Abdiel Absalón-Aguilar
    Marina Rull-Gabayet
    Alfredo Pérez-Fragoso
    Nancy R. Mejía-Domínguez
    Carlos Núñez-Álvarez
    David Kershenobich-Stalnikowitz
    José Sifuentes-Osornio
    Alfredo Ponce-de-León
    Fernanda González-Lara
    Eduardo Martín-Nares
    Sharon Montesinos-Ramírez
    Martha Ramírez-Alemón
    Pamela Ramírez-Rangel
    Manlio F. Márquez
    Juan Carlos Plata-Corona
    Guillermo Juárez-Vega
    Diana Gómez-Martín
    Jiram Torres-Ruiz
    Journal of General Internal Medicine, 2022, 37 : 4 - 14
  • [43] The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?
    Cai, Pengfei
    Mu, Yi
    McManus, Donald P.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease
    Bansal, Devendra
    Abdulmajeed, Jazeel
    Al-Shamali, Maha H. M. A.
    Albayat, Soha S. A.
    Himatt, Sayed M.
    Cyprian, Farhan S.
    Chivese, Tawanda
    Mundodan, Jesha M. A.
    Khogali, Hayat S.
    Baaboura, Rekayahouda
    Kaleeckal, Anvar H.
    Kandy, Mujeeb C.
    Latif, Ali Nizar
    Al-Kuwari, Mohamed Ghaith
    Al-Romaihi, Hamad Eid
    Al Khal, Abdullatif
    Bertollini, Roberto
    Al-Thani, Mohamed Hamad
    Farag, Elmobashar
    Doi, Suhail A. R.
    VACCINES, 2022, 10 (07)
  • [45] Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
    Andrews, Nick
    Tessier, Elise
    Stowe, Julia
    Gower, Charlotte
    Kirsebom, Freja
    Simmons, Ruth
    Gallagher, Eileen
    Thelwall, Simon
    Groves, Natalie
    Dabrera, Gavin
    Myers, Richard
    Campbell, Colin N. J.
    Amirthalingam, Gayatri
    Edmunds, Matt
    Zambon, Maria
    Brown, Kevin
    Hopkins, Susan
    Chand, Meera
    Ladhani, Shamez N.
    Ramsay, Mary
    Bernal, Jamie Lopez
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 340 - 350
  • [46] Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness
    Ferastraoaru, Denisa
    Hudes, Golda
    Jerschow, Elina
    Jariwala, Sunit
    Karagic, Merhunisa
    de Vos, Gabriele
    Rosenstreich, David
    Ramesh, Manish
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1152 - +
  • [47] Physical Activity Protects Against Severe Disease Due To Covid-19
    Hogan, Daniel E.
    Glace, Beth W.
    Kremenic, Ian J.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 313 - 313
  • [48] Mavrilimumab for severe COVID-19
    Khan, Adil Rashid
    Soneja, Manish
    Tirlangi, Praveen Kumar
    Wig, Naveet
    LANCET RHEUMATOLOGY, 2020, 2 (11): : E661 - E662
  • [49] Baseline Statin Use Appears to Protect Against Severe COVID-19
    Meyerowitz, Eric A.
    Kim, Arthur Y.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (12):
  • [50] Ruxolitinib and Severe COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INFECTION AND CHEMOTHERAPY, 2021, 53 (04): : 796 - 796